Logo

Sigma-Aldrich Completes Proligo Acquisition

Apr 04, 2005

NEW YORK, April 4 (GenomeWeb News) - Sigma-Aldrich announced last week that it has completed its acquisition of DNA and RNA maker Proligo from Degussa.

 

Financial terms of the transaction were not disclosed. According to Sigma-Aldrich, Proligo had 2004 sales of about $40 million.

 

Sigma-Aldrich first announced its intent to acquire Proligo in February.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.